Answers are grounded in this paper and cite their sources.
To avoid an invasive renal biopsy, noninvasive laboratory testing for the differential diagnosis of kidney diseases is a desirable goal. As sphingolipids are demonstrated to be involved in the pathogenesis of various kidney diseases, we investigated the possible usefulness of the simultaneous measurement of urinary sphingolipids for differentiating kidney diseases.
No takes yet. Share an insight, caveat, or question.
Morita et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: